Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 9 November 2024, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live News

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live News

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 May 2024Powered by Capital Market - Live News

Remus Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 21 May 2024 .Powered by Capital Market - Live News